Mustang Bio MBIO
NASDAQ MBIO
$0.44 -0.01 (-2.22%)
At close: Nov 11, 2026 · 4:00 PM EST

Mustang Bio (MBIO) Change in Acquisitions & Divestments (2017 - 2019)

Updated

Analysis

Mustang Bio (MBIO) Change in Acquisitions & Divestments (2017 - 2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Mustang Bio 3.03 Mn -60.03 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2019 5.10 Mn
Mar 31, 2019 12.50 Mn
Dec 31, 2018 10.00 Mn
Sep 30, 2018 25.00 Mn
Jun 30, 2018 12.00 Mn
Mar 31, 2018 14.00 Mn
Dec 31, 2017 20.00 Mn
API Access

Mustang Bio Change in Acquisitions & Divestments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-acquisitions-and-divestments&ticker=MBIO&period=max&api_key=YOUR_API_KEY